Frontlight ResearchEarly access
CompletedNo phase
ChitoCare Medical Wound Healing Gel PMCF Study on Healing of Chronic Wounds
Key facts
- Who runs it
- Primex ehf
- Where
- Croatia and Slovenia9 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 92 people enrolled
- Started
- 11 Jan 2022
- Ended
- 15 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- ChitoCare medical Wound Healing Gel
- Record updated
- 19 February 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Written informed consent must be given
- Patient ≥ 18 years old
- Presence of chronic wound (Wagner grade I and II diabetic foot ulcer, venous leg ulcer or pressure ulcer) that meets the following criteria:; Size of the wound ≥ 0.5 cm2; Wound is not infected at the time of randomization; Wound is present for at least 4 weeks
- Able to understand and comply with the requirements of the study
Who cannot take part
- Previous treatment under this clinical protocol
- Receiving or scheduled to receive a medication or treatment which, in the opinion of the investigator, was known to interfere with, or affect the rate and quality of wound healing
- Any significant condition that may preclude the participant from the study (e.g. severe depression or psychiatric illness)
- Patients that will require surgical procedure to treat their ischemic condition on the limb where the wound is present as assessed by the investigator
- Patients diagnosed with autoimmune connective tissue diseases
- Allergy to shellfish (for active study group)
- Medical condition likely to require systemic corticosteroids during the study period
- Patients with serious concomitant disease (cancer, heart failure (NYHA class IV), severe anaemia (Hb<100 g/L), neoplasia)
- Participation in another clinical trial
- Pregnant and lactating women
Where is this trial?
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
We are testing a gel intended for the protection and healing of chronic wounds as a support for standard therapy. The main component of the gel is chitosan, a natural polymer that has the ability to stop bleeding, has a positive effect on wound healing, and has antimicrobial properties.
The 2 groups in the trial
- Active groupTreatment being tested
Active group will apply ChitoCare medical Wound Healing Gel to the wound in addition to standard of care.
Treatment: ChitoCare medical Wound Healing Gel
- Control groupNo study treatment, for comparison
Control group will only administer standard of care to treat their wounds.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multi-Centre, Randomized, 2-arm, Open-labelled, Controlled PMCF Study to Evaluate the Safety and Performance of ChitoCare Medical Wound Healing Gel in Healing of Chronic Wounds
- Record updated
- 19 February 2025